Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

CB-5339 is an inhibitor of the AAA-ATPase p97, also known as valosin-containing protein (VCP; IC50 = 9 nM), and a derivative of CB-5083 (Item No. 19311).1 It inhibits phosphodiesterase 6C (PDE6C) and accumulates in rat retina to a lesser extent than CB-5083. CB-5339 inhibits the growth of 16 primary acute myeloid leukemia (AML) cell lines (median IC50 = 375 nM) and induces polyubiquitin protein accumulation and endoplasmic reticulum (ER) stress in MV4-11 AML cells. It decreases tumor cell bone marrow infiltration and increases survival in an MLL-AF9-driven patient-derived xenograft (PDX) mouse model of AML at 90 mg/kg.
WARNING This product is not for human or veterinary use.
1. Targeting acute myeloid leukemia dependency on VCP-